Pharma-Bio Serv (OTCMKTS:PBSV) Issues Quarterly Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSV) released its earnings results on Monday. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.35, reports. The company had revenue of $2.47 million for the quarter, compared to analysts’ expectations of $2.70 million. Pharma-Bio Serv had a negative return on equity of 5.61% and a negative net margin of 8.18%.

Pharma-Bio Serv Stock Down 21.8 %

Shares of OTCMKTS:PBSV opened at $0.43 on Wednesday. The company has a 50 day moving average of $0.55 and a two-hundred day moving average of $0.57. The company has a market capitalization of $9.86 million, a price-to-earnings ratio of -14.33 and a beta of 0.53. Pharma-Bio Serv has a 52-week low of $0.31 and a 52-week high of $0.90.

Pharma-Bio Serv Announces Dividend

The firm also recently announced a dividend, which will be paid on Thursday, March 20th. Investors of record on Friday, February 28th will be given a dividend of $0.075 per share. The ex-dividend date of this dividend is Friday, February 28th. Pharma-Bio Serv’s dividend payout ratio (DPR) is presently -250.00%.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.